[go: up one dir, main page]

AU2002227949A1 - Regulation of human fatty acid coa ligase - Google Patents

Regulation of human fatty acid coa ligase

Info

Publication number
AU2002227949A1
AU2002227949A1 AU2002227949A AU2794902A AU2002227949A1 AU 2002227949 A1 AU2002227949 A1 AU 2002227949A1 AU 2002227949 A AU2002227949 A AU 2002227949A AU 2794902 A AU2794902 A AU 2794902A AU 2002227949 A1 AU2002227949 A1 AU 2002227949A1
Authority
AU
Australia
Prior art keywords
regulation
fatty acid
coa ligase
acid coa
human fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227949A
Other languages
English (en)
Inventor
Alex Smolyar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002227949A1 publication Critical patent/AU2002227949A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002227949A 2000-12-01 2001-11-27 Regulation of human fatty acid coa ligase Abandoned AU2002227949A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25012300P 2000-12-01 2000-12-01
US60/250,123 2000-12-01
PCT/EP2001/013795 WO2002044351A2 (fr) 2000-12-01 2001-11-27 Regulation de la coa ligase humaine d'acides gras

Publications (1)

Publication Number Publication Date
AU2002227949A1 true AU2002227949A1 (en) 2002-06-11

Family

ID=22946378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002227949A Abandoned AU2002227949A1 (en) 2000-12-01 2001-11-27 Regulation of human fatty acid coa ligase

Country Status (2)

Country Link
AU (1) AU2002227949A1 (fr)
WO (1) WO2002044351A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462587A1 (fr) * 2001-12-19 2003-07-03 Exelixis, Inc. Modulation de la signalisation des recepteurs de l'insuline par ciblage de genes de facl (acyl-coa synthetase))

Also Published As

Publication number Publication date
WO2002044351A3 (fr) 2002-11-21
WO2002044351A2 (fr) 2002-06-06

Similar Documents

Publication Publication Date Title
AU3591301A (en) Ester derivatives of dimethylpropionic acid and pharmacetuical compositions containing them
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU2001222986A1 (en) Dehydroascorbic acid formulations and uses thereof
AU2002229644A1 (en) Cosmetic compositions for preventing skin irritation
AU2002227949A1 (en) Regulation of human fatty acid coa ligase
AU2002220698A1 (en) Regulation of human fatty acid coa ligase
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001256773A1 (en) Regulation of mt1-mmp activity
AU2002211561A1 (en) Regulation of human skin healing
AU6439400A (en) Skin cosmetic compositions for reducing skin irritation from weak carboxylic acids
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2003224361A1 (en) Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein
AU2002231620A1 (en) Regulation of human patched-like protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2001289723A1 (en) Novel use of difluoromalonic acid esters
AU2002221781A1 (en) Regulation of human inositolpolyphosphate 5-phosphatase
AU2001291789A1 (en) Use of l-ascorbic acid in cosmetic sunscreen emulsions
AU2002355343A1 (en) Human fatty acid-coa ligase
AU2002237225A1 (en) Regulation of human patched-like protein
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme